Nicholas Maestas
Patrimonio netto: 903 $ in data 31/05/2026
Patrimonio netto: 903 $ in data 31/05/2026
Nicholas Maestas is currently Chief Financial & Accounting Officer at Rani Therapeutics Holdings, Inc. since 2026.
Formerly, Mr. Maestas was Chief Financial Officer, Secretary & Head-Strategy at Tempest Therapeutics, Inc. from 2025 to 2026, Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021, and Senior Director-Corporate Development & Operations at Immune Design Corp.
in 2019.
Mr. Maestas completed undergraduate education at the University of California, Berkeley.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 590 ( 0% ) | 903 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Direttore Finanziario/CFO | 29/06/2026 |
| Società | Posizione | Fine |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Direttore Finanziario/CFO | 05/06/2026 |
| ALECTOR, INC. | Corporate Officer/Principal | 01/07/2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01/07/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale